Investors
SVLS primarily manages or advises limited partnership funds focused at providing corporate investors with exposure to the life sciences sector. If you are a corporate investor and would like to discuss our limited partnership funds, please contact James Garvey, Managing Partner.SVLS also manages International Biotechnology Trust plc ('IBT'), an investment trust vehicle listed on the London Stock Exchange into which both corporate and private investors may invest. For further information on this trust please see the dedicated website www.internationalbiotrust.com
Investment Strategy
SVLS's investment strategy is focused upon four sectors within the human life sciences industry; biotechnology/biopharmaceuticals, medical devices, healthcare services and healthcare information technology.The five funds that the SVLS team advise or manage are able to invest in Life Sciences businesses at all stages of development. Our four limited partnership funds focus on investing in equity or near equity securities in private businesses and our listed investment trust vehicle ('IBT') focuses on smaller public companies. We usually take a lead investor position within a strong investment syndicate structured to fully support the business in its objectives.
Geographically, SVLS funds concentrate their investment into businesses based in North America and Western Europe, but will consider investment opportunities in other regions, where there is a well-developed life sciences sector.
SVLS focuses on investments in companies with a very high quality management team and a business model that could provide a strong increase in value, often with a key technology or technologies protectable by law which allows the business to be developed shielded from competition. They may occupy a strong, preferably proprietary position in a large or niche market or may have an early position in a fast growing market.
